BARILARO, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.198
EU - Europa 3.470
AS - Asia 2.692
SA - Sud America 356
Continente sconosciuto - Info sul continente non disponibili 134
AF - Africa 111
OC - Oceania 22
Totale 11.983
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.077
RU - Federazione Russa 1.368
IT - Italia 772
CN - Cina 708
SG - Singapore 708
HK - Hong Kong 369
PL - Polonia 300
IE - Irlanda 283
VN - Vietnam 270
BR - Brasile 269
KR - Corea 206
SE - Svezia 189
FR - Francia 131
DE - Germania 121
FI - Finlandia 96
IN - India 91
CA - Canada 76
JO - Giordania 75
GB - Regno Unito 64
JP - Giappone 64
BD - Bangladesh 36
ES - Italia 33
AR - Argentina 32
CH - Svizzera 31
MA - Marocco 30
SA - Arabia Saudita 25
ID - Indonesia 24
NL - Olanda 24
TR - Turchia 24
ZA - Sudafrica 22
MX - Messico 21
AU - Australia 20
IR - Iran 19
EC - Ecuador 17
UA - Ucraina 16
EG - Egitto 14
CI - Costa d'Avorio 13
IQ - Iraq 13
NG - Nigeria 12
CO - Colombia 11
PK - Pakistan 11
LT - Lituania 8
UZ - Uzbekistan 8
VE - Venezuela 8
CL - Cile 7
BJ - Benin 6
MY - Malesia 6
NP - Nepal 6
AT - Austria 5
BE - Belgio 5
CZ - Repubblica Ceca 5
AZ - Azerbaigian 4
DZ - Algeria 4
IL - Israele 4
KE - Kenya 4
PA - Panama 4
PH - Filippine 4
PS - Palestinian Territory 4
UY - Uruguay 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
PE - Perù 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
BO - Bolivia 2
ET - Etiopia 2
GD - Grenada 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
MM - Myanmar 2
MQ - Martinica 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
AL - Albania 1
BG - Bulgaria 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MD - Moldavia 1
MU - Mauritius 1
NE - Niger 1
NO - Norvegia 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
Totale 11.847
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.314
Ashburn 650
Singapore 500
Hong Kong 329
Warsaw 295
San Jose 293
Dublin 282
Chandler 214
Seoul 206
Milan 196
Fairfield 188
Beijing 175
North Bergen 131
Hefei 129
Council Bluffs 114
Buffalo 96
Lawrence 95
Ho Chi Minh City 93
Altamura 91
Los Angeles 91
Woodbridge 79
Seattle 77
Munich 72
Florence 71
Rome 70
Dallas 65
Houston 62
Tokyo 62
Princeton 61
Hanoi 60
Lauterbourg 60
Boston 56
Cambridge 56
New York 55
Kent 54
Mumbai 52
The Dalles 52
Wilmington 49
Moscow 47
Shanghai 41
Ann Arbor 39
Helsinki 38
Paris 38
Turku 37
Clifton 36
Dearborn 33
São Paulo 29
Bern 27
Orem 25
San Diego 25
Casablanca 24
Frankfurt am Main 20
Medford 20
Brooklyn 19
Jakarta 19
Barcelona 18
Toronto 18
Boardman 17
Melbourne 17
Phoenix 17
Riyadh 17
Lappeenranta 16
Montreal 16
Chicago 15
Denver 15
Naples 15
Bologna 14
Chennai 14
Abidjan 13
Da Nang 13
London 13
Redondo Beach 13
Turin 13
Lakewood 12
Abuja 11
Johannesburg 11
Norwalk 11
Yubileyny 11
Falls Church 10
Manchester 10
Tianjin 10
Cagliari 9
Cairo 9
Haiphong 9
Jacksonville 9
Porto Alegre 9
Belo Horizonte 8
Biên Hòa 8
Istanbul 8
Rio de Janeiro 8
Stockholm 8
Amman 7
Amsterdam 7
Atlanta 7
Bengaluru 7
Figino 7
Guangzhou 7
Palermo 7
Quito 7
Buenos Aires 6
Totale 7.619
Salva come PNG Salva come JPEG
Nome #
Central vein sign differentiates MS from CNS inflammatory vasculopathies. 323
Progressive and atypical neurological symptoms in refractory systemic AL amyloidosis 304
Studio clinico aperto, randomizzato, sulla utilizzazione dell'associazione di βIFN1a ed azatioprina, in pazienti affetti da sclerosi multipla recidivante-remittente 243
Subgroup Comparison According to Clinical Phenotype and Serostatus in Autoimmune Encephalitis: A Multicenter Retrospective Study 236
Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis 220
A novel PAX1 null homozygous mutation in autosomal recessive otofaciocervical syndrome associated with severe combined immunodeficiency 212
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study 210
Acute cerebellar ataxia: a rare Toscana Virus (TOSV) meningoencephalitis complication 202
Accuracy of the central vein sign evaluation by brain MRI for the pathologic characterization of multiple sclerosis cases with markers of "better explanation" of the diagnosis. 200
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 198
Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experience 196
Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experience 193
Clinical and paraclinical findings in a case series of MOGAD: Exploring the presence of perivenular brain white matter lesions 193
Effect of disease-modifying treatments on antibody-mediated response to anti- COVID19 vaccination in people with multiple sclerosis 193
Efficacy of Azathioprine on Multiple Sclerosis new brain lesions evaluated using Magnetic Resonance Imaging. 189
Neuromyelitis optica, atypical hemophagocytic lymphohistiocytosis and heterozygous perforin A91V mutation. 189
Successful switch to ofatumumab after liver injury associated with ocrelizumab treatment in multiple sclerosis: a case report 183
Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies. 180
MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases. 180
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple Sclerosis. 179
The diagnosis of multiple sclerosis with markers of "better explanation": accuracy of the "central vein sign" in uncovering pathogenic mechansms different from inflammatory demyelination 178
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 177
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation 176
Short article: Safety of targeted prophylaxis strategy in patients with resolved hepatitis B virus infection receiving rituximab for immune-mediated diseases 175
CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis 175
A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet 175
Alice in wonderland syndrome “through the looking-glass” in a rare presentation of non-convulsive status epilepticus in cerebral venous sinus thrombosis and COVID-19 174
Anti-SARS-Cov2 vaccination at the time of the COVID-19 pandemic: suspected adverse events reporting is the milestone of post-marketing surveillance 174
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis 170
Long-term-video monitoring EEG and 18F-FDG-PET are useful tools to detect residual disease activity in anti-LGI1-Abs encephalitis: A case report 168
Efficacy of Azathioprine on Multiple Sclerosis new brain lesions evaluated by Magnetic Resonance Imaging. 168
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments 164
Imaging perivenular distribution can differentiate MS from CNS vasculitis. 163
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis 163
Reconstitution of natural or vaccination-driven immunity after aHSCT in multiple sclerosis 161
Case report: 3D intracranial vessel wall MRI in Susac syndrome: potential relevance for diagnosis and therapeutic management 159
Diagnostic accuracy of neurophysiological criteria for early diagnosis of AIDP: A prospective study 159
Kinetic of brain MRI gadolinium enhancing lesions in multiple sclerosis 158
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience 157
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation 156
Autoimmune epilepsy in drug resistent and in new onset refractory epilepsy 150
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: a population-based study on Tuscan residents 150
Long term follow-up of autologous stem cell transplantation (HSCT) for the treatment of secondary progressive multiple sclerosis: single centre experience 148
MMP9 index as possible diagnostic marker of Neuro-Behcet's disease 146
POLYNEUROPATHY ASSOCIATED WITH MONOCLONAL GAMMOPATHY: AN OBSERVATIONAL STUDY 146
Cerebral perfusion abnormalities in multiple sclerosis patients with markers of systemic autoimmunity 146
Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments 145
Anti-MAG IgM: differences in antibody tests and correlation with clinical findings 145
Comparison of azathioprine and of beta interferon efficacy on measures of brain damage evaluated by MRI in relapsing-remitting multiple sclerosis 144
Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis. 144
The Central Vein Sign identifies patients diagnosed with multiple sclerosis probably carrying different diseases and showing milder disease course 144
Leptomeningeal Gadolinium Enhancement in Autoimmune GFAP Astrocytopathy 144
Azathioprine versus interferon-beta-1a s.c.: efficacy on prevention of new brain lesions in relapsing-remitting multiple sclerosis 143
The spectrum of auto-immune encephalitis: Clinical characterisation and comparison between different syndromes defined by 2016 diagnostic criteria 143
In vivo dynamic neuropathology of brain new lesions in multiple sclerosis 142
Antigen Driven T-Cell Response in CSF of Multiple Sclerosis Patients 142
Natural history of brain inflammatory lesions in multiple sclerosis: a FLAIR and T1w post contrast MRI volumetric analysis 141
Direct comparison of Azathioprine and Interferon beta 1a efficacy on prevention of new brain lesions in relapsing-remitting multiple sclerosis 140
Time Course of Multiple Sclerosis Lesions Visualized with MRI: Insight into Focal Pathology 138
Comparing human bone marrow mesenchymal stem cells isolated from MS patients with ND ones: possible impact on MS therapy and immunopathology 137
Azathioprine-interferon beta 1a s.c. association in relapsing-remitting multiple sclerosis: compliance and efficacy in prevention of new brain lesions 137
HSCT for severe multiple sclerosis with BEAM/ATG: impact on female fertility 135
Azathioprine and interferon beta1a relative efficacy on prevention of new brain lesions in relapsing remitting multiple sclerosis 125
Purely myeloablative conditioning regimen in aggressive multiple sclerosis: two case reports 125
Intermediate intensity regimen in autologous HSCT for severe multiple sclerosis: a large, single center experience 124
intermediate intensity regimen in autologous HSCT for severe Multiple Sclerosis: a a large, single center experience 122
Post-infective neuromuscular hyperexcitability syndrome in a young man with cystic fibrosis: A case report 120
Impact of new DMAs on the safety profile of patients undergoing autologous haematopoietic stem cell transplantation for Multiple Sclerosis 119
Effectiveness and safety of intravenous immunoglobulin for peripheral neuropathy in EGPA patients: a retrospective study 118
Treating the Different Phenotypes of Behçet's Syndrome 107
Neuropathic pain in CASPR2 antibody disease spectrum: A systematic review 92
Modulating DC from immunogenic to tolerogenic responses: a novel mechanism of azathioprine (AZA) 90
Autologous haematopoietic stem cell transplantation affects long-term progression independent of relapse activity in aggressive multiple sclerosis: a comparative matched study 68
Validation of the "Patient-Acceptable Symptom State" Question as Outcome Measure in AChR Myasthenia Gravis: A Multicentre, Prospective Study 50
Totale 11.983
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.060
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.060
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022337 0 0 15 27 7 13 13 35 17 13 69 128
2022/20231.199 86 244 88 32 60 211 160 66 167 4 43 38
2023/2024600 22 70 65 42 51 63 24 110 32 28 55 38
2024/20253.815 148 371 251 594 989 601 65 225 159 84 137 191
2025/20264.359 538 587 377 473 496 135 484 155 274 255 136 449
2026/2027574 152 262 160 0 0 0 0 0 0 0 0 0
Totale 11.983